Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Merck
Harvard Business School
Express Scripts

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Septodont Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SEPTODONT, and what generic alternatives to SEPTODONT drugs are available?

SEPTODONT has eight approved drugs.

There are five US patents protecting SEPTODONT drugs.

There are thirty-one patent family members on SEPTODONT drugs in twenty countries.

Summary for Septodont
International Patents:31
US Patents:5
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Septodont

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont Inc ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084697-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Septodont Inc PRILOCAINE HYDROCHLORIDE prilocaine hydrochloride INJECTABLE;INJECTION 079235-001 Sep 29, 2010 RX No Yes   Start Trial   Start Trial
Septodont Inc ISOCAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 080925-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Septodont Holding ORAVERSE phentolamine mesylate INJECTABLE;INJECTION 022159-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial
Septodont BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 077250-001 Sep 27, 2006 AP RX No No   Start Trial   Start Trial
Septodont Inc LIDOCAINE lidocaine OINTMENT;TOPICAL 040911-001 May 23, 2011 AT RX No No   Start Trial   Start Trial
Septodont Inc PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 078959-001 Aug 30, 2011 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKesson
Boehringer Ingelheim
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.